Related by context. All words. (Click for frequent words.) 72 License Agreement 70 Licensing Agreement 69 Patent License Agreement 67 Agreement 67 License Option Agreement 67 Distribution Agreement 66 Supply Agreement 66 Commercialization Agreement 64 Teaming Agreement 63 Licence Agreement 63 Exclusive License Agreement 62 Joint Venture Agreement 62 Agreements 62 Purchase Agreement 61 Reseller Agreement 61 Exclusive License 60 Licensing Agreements 59 Cross License Agreement 59 Affiliation Agreement 59 Supply Agreements 59 Definitive Agreement 59 Sublicense Agreement 59 Termination Agreement 58 Share Purchase Agreement 58 CRADA 58 Definitive Merger Agreement 58 License Pact 58 Cooperation Agreement 58 Acquisition Agreement 57 Strategic Alliance 57 Lease Agreement 57 Cross Licensing Agreement 57 Definitive Agreements 57 Settlement Agreement 57 Loan Agreement 57 Asset Purchase Agreement 57 Binding Agreement 56 Agreement SEDA 56 Option Agreement 56 Confidentiality Agreement 56 Distributor Agreement 56 Stock Purchase Agreement 56 MOU 56 Receives Milestone Payment 56 Transfer Agreement 55 Cooperation Agreements 55 Sponsorship Agreement 55 LOI 55 Exclusive Licensing Agreement 55 Exclusivity Agreement 55 Assignment Agreement 55 Distribution Agreements 55 Initiates Clinical 55 Patent Covering 55 License Agreements 55 Signs License Agreement 55 Worldwide Licensing Agreement 55 Obtains License 55 Securities Purchase Agreement 54 Distributorship Agreement 54 Announces License Agreement 54 Combination Agreement 54 Develop Novel 54 Licensing Deal 54 Partnership Agreement 54 Framework Agreement 54 definitive agreement 54 Formal Agreement 54 Galderma SA 54 Standstill Agreement 53 Licensing Pact 53 Letter Agreement 53 Patent Licensing Agreement 53 Milestone Payment 53 Biomarker Study 53 BioSante Pharmaceuticals Announces 53 Representation Agreement 53 Announce Collaboration Agreement 53 Amended Agreement 53 Development Agreement CRADA 53 binding Letter 52 Forbearance Agreement 52 definitive agreements 52 Subscription Agreement 52 Signs Licensing Agreement 52 Taiho Pharmaceutical 52 Milestone Payments 52 Enters Into Agreement 52 Term Sheet 52 Purchase Agreements 52 Submits Application 52 commercialize Aganocides 52 Enters Into Licensing Agreement 52 Subsidiary Enters 52 Definitive Purchase Agreement 52 Extends Collaboration 52 Handok Pharmaceuticals 52 Signs Agreements 52 sublicense 51 Merger Agreement 51 Polysilicon Supply Agreement 51 Settlement Agreements 51 Contribution Agreement 51 Commitment Letter 51 Articulation Agreement 51 Fovea Pharmaceuticals 51 Terminates Merger Agreement 51 agreement 51 Files IND 51 Formal Option Agreement 51 Receive Milestone Payment 51 JHP Pharmaceuticals LLC 51 Enters Agreement 51 Announces Definitive Agreement 51 Merger Transaction 51 Forms Joint Venture 51 NV Organon 51 Amends Agreement 51 Inks Pact 51 agreements 51 Signs Memorandum 51 Licenses Novel 51 Regains Full 51 Enters Into Definitive 51 Distribution Pact 51 Clinical Trials Agreement 51 Enters Into Collaboration 50 commercialize Dimebon 50 Dendritic Nanotechnologies Inc. 50 Implementation Agreement 50 Enters Into Joint Venture 50 Initiates Phase II 50 Receives Confirmation 50 Joint Venture 50 Announce License Agreement 50 Restated Agreement 50 Option Agreements 50 Settles Litigation 50 Executes Agreement 50 agreementwith 50 Signs Definitive 50 Securities Purchase Agreements 50 Waiver Agreement 50 Announce Licensing Agreement 50 Initiates Clinical Trial 50 Settlement Agreement Regarding 50 subsidiary Biovail Laboratories 50 Material Transfer 50 Financing Agreements 50 Signs MOU 50 Offtake Agreement 50 Misonix Announces 50 Enters Into Strategic 50 Cenomed 50 MoU 50 Binding Letter 50 Participation Agreement 50 Non Binding Letter 50 Expand Collaboration 50 Amalgamation Agreement 50 Obtains Exclusive License 50 Master License Agreement 50 Complete Merger 50 Announce Joint Venture 50 sanofi aventis EURONEXT SAN 50 Presents Preclinical Data 50 acne impetigo 50 Exercises Option 50 Joint Venture JV 50 Acacia Subsidiary Enters 50 Announce Licensing 50 Sublicense 50 BioGeneriX 50 Oral Calcitonin 49 Announces Licensing Agreement 49 Amending Agreement 49 Completes Patient Enrollment 49 Strategic Relationship 49 Announce Agreement 49 Collaboration 49 Sign License Agreement 49 SRL Biovail 49 Elan Pharma 49 Dynepo TM 49 Sign Licensing Agreement 49 Sankyo Pharma 49 Miraculins Announces 49 Announce Collaboration 49 Acquires Exclusive 49 Oncolys 49 Receives Notification 49 Earns Milestone Payment 49 RNAi Therapeutics 49 Joint Venture Agreements 49 Mutually Agree 49 Enters Into Definitive Agreement 49 Quark Biotech 49 Closes Merger 49 Nippon Kayaku 49 Milestone Payment From 49 Syntonix 49 Achieves Milestone 49 Memorandum 49 Antibody Discovery 49 BioGeneriX AG 49 licensing agreements 49 SpeBio joint venture 49 Submits Response 49 UMN Pharma 49 Completes Asset 48 Exclusive Distribution 48 Medigen 48 definitive documentation 48 Signs Option Agreement 48 Systemic Delivery 48 CORLUX CORT # 48 Receives Orphan Drug Designation 48 Kaketsuken 48 Committed Equity 48 lixivaptan 48 Joint Venture Agreement JVA 48 Completes Enrollment 48 Outsourcing Contract 48 HSR Waiting Period 48 Synerx 48 Recombinant Protein 48 Signs Definitive Agreement 48 Definitive Option Agreement 48 Urocidin TM 48 Inks Licensing Deal 48 Announce Merger Agreement 48 Agreements FTAs 48 Stockholders Approve Merger 48 Signs Merger Agreement 48 License Application 48 Signs Joint Venture 48 POTELLIGENT R Technology 48 Asset Purchase Agreements 48 TRX1 48 Inks Agreement 48 Standby Equity Distribution 48 Submits IND 48 Agreement JOA 48 Announces Tentative Approval 48 Alnylam Nasdaq ALNY 48 Regains NASDAQ 48 Inks MOU 48 Completes Previously Announced 48 Signs Binding Letter 48 Collaborators Publish 48 Completes Financing 48 InvaGen 48 Seikagaku Corporation 48 Signs Non Binding 48 Debiopharm 48 Signs Agreement 48 A5 Laboratories Inc. 48 Signs Lease 48 Secures Financing 48 Tanabe Seiyaku 48 Patent Dispute 48 Wafer Supply 48 Diagnostica 48 commercialize telaprevir 48 Strategic Partnership 48 Establish Joint Venture 48 Enters Into License Agreement 48 Testosterone Gel 48 Study Validates 48 commercialize Aganocide compounds 48 Initiates Enrollment 48 Extend Collaboration 48 Sign Definitive Agreement 48 Subsidiary 48 Commercialize 47 Receives Fast Track 47 Small Molecule 47 Evolva 47 NASDAQ CGEN announced 47 Confidentiality Agreements 47 outlicensed 47 STO SOBI 47 Previously Announced 47 BioOne Corporation 47 Amend Merger Agreement 47 Sanochemia Pharmazeutika AG 47 Enters Joint Venture 47 NASDAQ Listing Requirements 47 Gets FDA Clearance 47 Initiates Phase 2b 47 Conditional Approval 47 EyeTel 47 Completes Transaction 47 elbion 47 Receives Complete Response 47 Inks Supply 47 Farmout Agreement 47 Reaches Agreement 47 Settles Patent Litigation 47 Announce Commencement 47 Ucyclyd Pharma Inc. 47 Potelligent Technology 47 Daewoong 47 Inks Licensing Agreement 47 Confirms Commitment 47 Develops Novel 47 Schizophrenia Drug 47 GlaxoSmithKline Biologicals SA 47 Terminates Agreement 47 OTC ZEGERID 47 Enter Into 47 AMEX RGN 47 Files Patent Application 47 Merck Serono Nycomed 47 Purchase Option Agreement 47 PharmaBio Development 47 Completes Merger 47 Value Added Reseller Agreement 47 OTCBB PYTO FWB ET6 47 Patent Infringement Litigation 47 Anti CD# Antibody 47 VaxImmune 47 Emisphere Technologies Announces 47 Secures Patent 47 Receives Clearance 47 Rheumatoid Arthritis Drug 47 Patents Covering 47 sublicensee 47 Initiates Dosing 47 Receives Tentative Approval 47 Contract 47 Psoriasis Drug 47 Prometheus Laboratories 47 Enters Into Agreements 47 Initiates Clinical Trials 47 Licence Agreements 47 FDA Accepts 47 Osiris retains 47 Arbitration Proceeding 47 Nasdaq Listing Requirements 47 Receives Tentative FDA 47 commercialize dimebon latrepirdine 47 Signs MoU 47 Mundipharma 47 AB OMXS BINV 47 Tibotec BVBA 47 Receives Funding 47 Pending Merger 47 Terminates Contract 47 Announces Stockholder Approval 47 Acquisition Proposal 47 outlicensing 47 Mentor Protege Agreement 47 Orapred ODT 47 Signs Licensing 47 OTCBB NVDL 47 Contract Renewal 47 Receives Regulatory 47 Unsolicited Tender Offer 47 DOR BioPharma Announces 47 Cooperation Framework Agreement 47 Begins Shipment 47 Formal Agreements 47 Therapeutic Competitors Report 47 PentaStaph 46 Receives Approval From 46 GenWay Biotech 46 Patent Issued 46 Samjin 46 Portola Pharmaceuticals Inc. 46 Neurimmune 46 Cellegesic 46 Enters Into Exclusive 46 Clearford Announces 46 Lease Renewal 46 Withdraws Application 46 Material Definitive Agreement 46 Transfer Agreements 46 Alopexx 46 BXT # 46 Agreements FTA 46 Receives Approval 46 Obtains Exclusive Rights 46 Demonstrates Ability 46 Successfully Concludes 46 Terminate Merger Agreement 46 Daiichi Suntory Pharma 46 Consent Agreement 46 Pending Litigation 46 iPS Academia Japan 46 Nycomed GmbH 46 Molecular Biotechnology CMB 46 Fresenius Biotech 46 Regains Compliance 46 Subsidiary Enters Into 46 Reports Preclinical Data 46 Enters Strategic 46 Inks License 46 binding LOI 46 Finalizes Joint Venture 46 Agreement DR CAFTA 46 Teijin Pharma Limited 46 Sanvar R 46 Pharmaceuticals Initiates 46 ZALBIN ™ 46 Financing Facility CEFF 46 InterfeRx 46 Signs Pact 46 Boehringer Ingelheim MedImmune 46 Receives Orphan Drug 46 Current Merger Agreement 46 Zor Pharmaceuticals 46 Receives Favorable 46 OMJPI 46 binding Memorandum 46 euro adhoc Intercell AG 46 Galenea 46 Therapeutic Antibody 46 Key Milestones 46 Secures Long Term 46 Escrow Agreement 46 Financing Transactions 46 Expands Portfolio 46 Receives Patent 46 Receives Favorable Ruling 46 Issued Patent 46 Proposed Qualifying Transaction 46 HHSN#C 46 Granted Orphan Drug 46 JAK2 Inhibitor 46 Protection Agreement BIPPA 46 FORMA Therapeutics 46 Expands Scope 46 Kwang Dong 46 Rheoscience 46 Proposed Acquisition 46 X Ceptor 46 Power Purchase Agreement 46 commercialize OncoGenex lead 46 Medicilon 46 Patent Infringement Case 46 Licenses Patents 46 Vaccine Adjuvants 46 Agreement HoA 46 Recapitalization Agreement 46 Option Grants 46 ELADUR TM 46 Generic Version 46 Nano Terra 46 Enter Into Definitive 46 Jaiva Technologies 46 Acquire Assets 46 Enters Into Long Term 46 Expanded Indication 46 Flamel Technologies Announces 46 Crucell Announce 46 Enters Into 46 Sign Definitive Merger 46 Exclusivity Period 46 InNexus Biotechnology 46 Interconnection Agreement 46 Handok 46 GTC NASDAQ GTCB 46 Biotech Firm 46 Finalizes Acquisition 46 Fast Track Status 46 Obtains Approval 46 Receives Notice 46 Regulatory Approvals 46 Roaming Agreement 46 Patent Broadly Covering 46 Farmout 46 NQCI 46 Jointly Announce 46 Announces Definitive Merger 46 Regains Nasdaq 46 Asset Sale 46 Final Approval 46 Bio3 Research 46 Successful Completion 46 Submits NDA 46 candidate custirsen 46 Global Reseller Agreement 46 RAPTIVA R 46 Azur Pharma 46 TSX SHQ 46 Nasdaq HALO 46 DARA logo 46 Arrangement MFA 46 MedGenesis 46 Primus Pharmaceuticals 46 Disposition Agreement 46 Patent Portfolio 46 Terminate Agreement 46 commercialize elagolix 46 IntelliPharmaCeutics Ltd. 46 Achieves Significant 46 Announces FDA Clearance 46 Proxy Proposals 46 AnGes 46 Purchase Agreement dated 46 Forges Partnership 46 commercializing Loramyc ® 46 Finalizes Agreement 46 Not Disclosed 46 Millenia Hope Biopharma 46 Antisense Drug 46 Announces Termination 46 Wins Approval 46 Signs LOI 46 Norgine BV 46 Reach Settlement Agreement 46 sublicensing agreements 46 Entered Into 46 Biomarin 46 Announces Issuance 46 HuCAL antibodies 45 Completes Recapitalization 45 NYSE Amex BTX 45 Idenix Novartis 45 Acquire Majority 45 MorphoSys proprietary 45 Submits Biologics License Application 45 Announce Expiration 45 Announces Initiation 45 proprietary radiolabeled monoclonal 45 Convertible Promissory Note 45 Million Financing 45 Idec Roche Takeda 45 FDA Clears 45 commercialize Hematide 45 Reverse Takeover 45 Proposed Merger 45 Receives Shareholder Approval 45 Therapeutic Competitors Companies 45 Enters Into Letter 45 Framework Agreements 45 Announce Early Termination 45 Patent Reexamination 45 commercialize taliglucerase alfa 45 Restructures Operations 45 Strengthens Its 45 Recapitalization Transaction 45 ARCALYST R 45 Holders Approve 45 RYZOLT TM 45 Agree ment 45 Underwriting Agreement 45 Genpharm 45 Closes Financing 45 Vitaros R 45 Proposed Transactions 45 mGluR2 positive 45 Expedited Review 45 Nasdaq CLDX 45 Announces Successful Completion 45 Seeks Approval 45 Acknowledges Receipt 45 Protection Agreement BIPA 45 VIVITROL ® 45 CHDI Foundation 45 Patents Issued 45 Settle Patent Litigation 45 Eligard R 45 Closes Sale 45 Portola Pharmaceuticals 45 Receives Commitment 45 Arbitration Proceedings 45 Strengthens Position 45 Gentamicin Surgical Implant 45 NanoTherapies 45 joint venture 45 definitive Arrangement Agreement 45 Expand Relationship 45 Janssen Pharmaceutica NV 45 MBMI Closes 45 Shareholders Approve Merger 45 Oncologix 45 Reaches Settlement Agreement 45 Announce Receipt 45 Loramyc ™ 45 Completes Expansion 45 Sigma Tau Pharmaceuticals 45 Listings Policy 45 PharmaBio 45 Acquisition 45 Vaccinex 45 JUVISTA 45 Secures Contract 45 Cardioxyl Pharmaceuticals 45 Researchers Identify 45 Awarded Multi 45 Inc. OTCBB VIVK 45 Receives CE Marking 45 Kiadis 45 Bayer Yakuhin 45 Kissei Pharmaceutical 45 developing biomedical countermeasures 45 Paris IPN Euronext 45 Tolling Agreement 45 Pending Acquisition 45 Lung Cancer Drug 45 DIP Loan 45 Fancamp Announces 45 JV SpeBio 45 Share Issuance 45 Merck Serono SA 45 Antibody Drug Conjugate 45 Medicure Announces 45 Announce Intention 45 Secures Exclusive 45 Development OTD 45 Endotis 45 Closes Previously Announced 45 Receives FDA Approvable 45 Novel Vaccine 45 EHT AGN 45 Patent Infringement Lawsuit Against 45 Development Authority BARDA 45 Discontinues 45 Nippon Shinyaku 45 Paladin Labs 45 Acquistion 45 AnGes MG 45 OTCBB PYTO 45 Affitech 45 Ceragenix 45 Sanofi Chimie 45 Forges Strategic 45 Obtains Patent 45 Submits Supplemental 45 Due Diligence Period 45 Credit Agreement 45 Merck Serono division 45 Acquire Controlling Interest 45 Enters Definitive Agreement 45 Enters Into Settlement Agreement 45 Receives Conditional 45 Awarded Qualifying Therapeutic 45 Ercole Biotech 45 Teijin Pharma 45 OncoTherapy Science 45 Diamyd Medical Diamyd 45 Presents Positive 45 POTELLIGENT R 45 Binding Offer 45 definitive merger 45 dacetuzumab collaboration 45 Task Force ACTF 45 commercialize pimavanserin 45 Proposed Combination 45 mutually acceptable definitive 45 Restated Promissory Note 45 Nasdaq ABII 45 Reacquires 45 Receives NASDAQ 45 Pennsaid R 45 Multimillion Dollar Contract 45 Fumapharm AG 45 Zygogen 45 Prodarsan R 45 Amends Terms 45 ENZON 45 DeveloGen 45 Extends Tender Offer 45 Trastuzumab DM1 45 Collaborates 45 Consent Order 45 Laboratory Practice GLP 45 Color Additives 45 Settles Patent Infringement Lawsuit 45 Settle Litigation 45 SYCREST 45 Modification Agreement 45 Announce Settlement 45 Patent Infringement Lawsuit 45 Files Shelf Registration Statement 45 Product Designation 45 CEFF financings subject 45 sublicensed 45 IPSEN 45 Photovoltaic Module 45 NASDAQ ALNY 45 Accelrys Announces 45 Successfully Completes Tender Offer 45 Unsolicited Proposal From 45 Paragraph IV Certification 44 SYN X 44 Announce Shareholder Approval 44 International SRL BLS 44 Extend Partnership 44 Million Milestone Payment 44 Settle Patent Dispute 44 Strengthens Balance Sheet 44 GP Holdings L.P. 44 Establishes Joint Venture 44 EPC Contract 44 Restructures 44 PhytoMedical Technologies Inc. 44 exclusive sublicense 44 Stockholder Approval 44 Patent Lawsuit 44 Gendux AB 44 Develop Next Generation 44 Subsidiary Signs 44 Identifies Potential 44 XIAPEX 44 Announce Definitive Agreement 44 staphylococcal vaccines 44 Celera Diagnostics joint venture 44 farmout agreement 44 Juvantia 44 Biologics Manufacturing 44 Merck OSI Pharmaceuticals 44 Raven Biotechnologies 44 entity NCE 44 OTCBB APCSF 44 commercialize AzaSite 44 Order Approving 44 HepeX B 44 Diatos SA 44 Announces Intent 44 Prestara 44 Fragment Based 44 Oncolys BioPharma 44 Sensipar R 44 Receives Notice From 44 Successful Conclusion 44 Approve Merger 44 Clinical Trial Enrollment 44 Inks LOI 44 FY# Loss Widens 44 NeoGenesis 44 Codeshare Agreement 44 glucokinase activator 44 Extends Relationship 44 Patent Litigation 44 supplemental indentures 44 Rozetta Cell 44 HuMax TAC 44 Janssen AI 44 Executes Binding 44 Asset Swap 44 Biovitrum AB 44 upfront payment 44 Conditions Precedent 44 Kosan dependence 44 Subsidiary Wins 44 Molecular Diagnostic Test 44 Lexiscan TM 44 copromotion 44 Vicor Technologies Announces 44 AnGes MG Inc. 44 Promissory Note 44 Announces Consummation 44 Spins Out 44 Recapitalization Plan 44 Completes Buyout 44 Joint Statement 44 Commencement Date 44 Stock Repurchase Plan 44 Renews Multi 44 Arrangement Agreement 44 OTCBB HXBM developer 44 Japanese Encephalitis Vaccine 44 Taglich Brothers Initiates Coverage 44 Second Tranche 44 Cenix BioScience 44 EMD Biosciences Inc. 44 Shareholders Approve Proposed 44 Inks Multi 44 Captisol ® 44 Genpharm Inc. 44 theagreement 44 Shareholders Approve Acquisition 44 CIP TRAMADOL ER 44 Dongbao 44 anti CD3 monoclonal 44 Consent Decree 44 Intractable Hiccups 44 Flagship Product 44 contractual agreements 44 Third Supplemental Indenture 44 Completes Reverse Merger 44 Cephalon GlaxoSmithKline 44 Derma Sciences Announces 44 Demonstrates Sustained 44 ESTRASORB R 44 Presents Preclinical 44 Urokinase 44 Biovail Laboratories 44 PLAVIX ® 44 Second Amended 44 Patent Upheld 44 Cellgate Inc. 44 Boehringer Ingelheim CHDI Novartis 44 Property Option Agreement 44 Private Placement Closed 44 Agreement KORUS FTA 44 Stock Exchange EVT TecDAX 44 AERx iDMS 44 Consummates 44 & LSE GLPG 44 Acquires Majority 44 Agreement CEFTA 44 Hyperion Catalysis International 44 Multi Billion Dollar 44 Kedrion 44 Acceptys 44 Influenza Vaccine Production 44 Closes Acquisition 44 MERREM IV 44 Announces Receipt 44 Completes Merger With 44 sub licensable 44 DOV Pharmaceutical 44 Pact 44 CYOE 44 Scil 44 Proposed Arrangement 44 Implementation Deed 44 Asubio 44 Successfully Closes 44 Announces Shareholder Approval 44 Million Dollar Contract 44 Teikoku Seiyaku 44 Terminates Letter 44 Private Placement Offering 44 BLSI 44 Plea Agreement 44 Files Provisional 44 Sanochemia 44 Amended Option Agreement 44 Inc Therapeutic Competitors 44 FDA Okays 44 Updates Status 44 Accelerate Commercialization 44 Completes Sale 44 Completes Purchase 44 Wellstat Therapeutics 44 collaboration 44 Negotiates 44 Aldara ® 44 Synerx Pharma 44 Gruppo Angelini 44 BioSyent Pharma 44 Dalian Liyang 44 Wholly Owned Subsidiary 44 Metabolic Disease 44 supplemental indentures effecting 44 Finalizes Contract 44 Option Deed 44 GVK Biosciences 44 Indentures 44 Chemo Sero Therapeutic 44 Provides Clarification 44 TRANSDUR ™ 44 Loramyc TM 44 Resale Registration Statement 44 RxKinetix 44 Prostate Cancer Vaccine 44 Settle Patent Lawsuit 44 wholly ownedsubsidiary 44 Signs Binding 44 Enters Exclusive 44 Expands Scientific Advisory 44 Avian Flu Vaccine 44 affiliate Evogene Ltd. TASE 44 Acacia Subsidiary 44 Presents Positive Preclinical 44 Merger Sub 44 Nasdaq IDEV 44 Provides Update Regarding 44 Fidelity Biosciences 44 Previously Announced Private Placement 44 Receives FDA Clearance 44 Regulatory Clearance 44 Completes Tender Offer 44 Announce Completion 44 HoA 44 Therapeutic Antibodies 44 resolves patent infringement 44 Rottapharm Madaus 44 Inc. TSX PLI 44 Agreement FTA 44 Completes Acquisitions 44 farmin agreement 44 Ink Pact 44 Galderma Pharma 44 SAR# [002] 44 Islet Transplantation 44 Captisol 44 Relieva 44 Yissum Research 43 Area Safta 43 FY# Loss Narrows 43 Establishes Strategic 43 Receives SFDA Approval 43 Roche SWX ROG 43 Loan Facility 43 Protein Therapeutics 43 Nanobody R 43 Restructures Debt 43 Announces Definitive Agreements 43 oral taxane 43 GenWay Biotech Inc. 43 HuCAL GOLD R 43 Expand Scope 43 Immunomedics Announces 43 Signs LoI 43 Tyzeka Sebivo 43 Strengthens Relationship 43 Concession Agreement 43 Million Private Placement 43 Drug Shows Promise 43 Expands Relationship 43 Completes Acquisition 43 Production Sharing Agreement EPSA 43 rxRNA 43 Reseller Relationship 43 BioElectronics Corporation Announces 43 Jointly Explore 43 Ebola Vaccine 43 Awarded Contracts 43 Subsidiary Awarded 43 LGLS 43 Gestiva TM 43 Lupin Pharmaceuticals 43 Taisho Pharmaceuticals 43 Explores Strategic Alternatives 43 Methylphenidate Transdermal System 43 Closes Private Placement 43 ESTRASORB ® 43 Tech DVAX 43 Kyowa Kirin 43 Gastrotech 43 Nasdaq ALNY 43 PerkinElmer Acquires 43 Sale Transaction 43 TB Vaccine 43 Product Commercialization 43 Oracea ® 43 Nasdaq CGEN 43 Enrolls First 43 MOU Memorandum 43 Provides Shareholder 43 eprodisate KIACTA TM 43 CIMZIA r 43 Enters Into Memorandum 43 Therapeutic Vaccines 43 Kuhnil 43 Protiva Biotherapeutics Inc. 43 Non Aggression Pact 43 fifty fifty joint venture 43 Broadens Its 43 Expands Internationally 43 Regulatory Submissions 43 Fortical ® 43 Javelin Pharmaceuticals 43 Successfully Complete 43 tramiprosate ALZHEMED TM 43 Inks Contract 43 Granted Early Termination 43 Subsidiary Acquires 43 Reexamination Certificate 43 Akrimax 43 OTCBB CPEU 43 Syntonix Pharmaceuticals 43 Memoranda 43 CFFT 43 forbearance agreement 43 greement 43 Bayer Schering 43 Expands Relationship With 43 Japanese drugmaker Daiichi 43 Nasdaq XTLB 43 Zeneus 43 PAION AG 43 Nuclear Receptors 43 Formalizes 43 Metabolic Disorder 43 Renews Exclusive 43 Servicing Agreement 43 Long Term Lease 43 Streamlines Operations 43 Broadens Scope 43 ASX PGL 43 Cellpep 43 Announces Spin Off 43 Collaborates With 43 Stipulation 43 Novartis NVS Snapshot Report 43 Announce Interoperability 43 NASDAQ FLML 43 Announces Signing 43 Board Authorizes 43 BioGlue R 43 NasdaqGM SPPI 43 Pacts